Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
On September 29, 2022, the Food and Drug Administration (FDA) approved AMX0035 for the treatment of amyotrophic lateral sclerosis (ALS),…
Current guidelines warn against the use of intravenous thrombolysis in patients with ischemic stroke and recent direct oral anticoagulant (DOAC)…
A wealth of research continues to investigate anticoagulation-associated intracranial hemorrhage and the optimal strategies for prevention and management…
The first interim data has been published from a Phase I/II trial testing the safety and tolerability of AMT-130. If…
The role of BTK inhibitors (BTKis) in cancer treatment has been well-established, but what prospects do they have in treating…
Myasthenia gravis (MG) is a rare disorder, exhibiting the archetypic traits of both the neuromuscular junction and autoantibody-mediated disease –…
The 7th annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) brought together experts to share the latest…
The European Stroke Organisation (ESO) has published new guidelines for prehospital management of suspected stroke patients, and recommendations, in collaboration…